about
Salmonella uses energy taxis to benefit from intestinal inflammationVery long O-antigen chains enhance fitness during Salmonella-induced colitis by increasing bile resistanceMalaria parasite infection compromises control of concurrent systemic non-typhoidal Salmonella infection via IL-10-mediated alteration of myeloid cell function.Innate immune recognition of flagellin limits systemic persistence of BrucellaInteractions of the human pathogenic Brucella species with their hosts.The mucosal inflammatory response to non-typhoidal Salmonella in the intestine is blunted by IL-10 during concurrent malaria parasite infectionThe predicted ABC transporter AbcEDCBA is required for type IV secretion system expression and lysosomal evasion by Brucella ovis.CD4+ T cell-derived IL-10 promotes Brucella abortus persistence via modulation of macrophage function.Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiotaA Salmonella virulence factor activates the NOD1/NOD2 signaling pathway.Inflammation-associated alterations to the intestinal microbiota reduce colonization resistance against non-typhoidal Salmonella during concurrent malaria parasite infection.Depletion of Butyrate-Producing Clostridia from the Gut Microbiota Drives an Aerobic Luminal Expansion of SalmonellaRespiration of Microbiota-Derived 1,2-propanediol Drives Salmonella Expansion during Colitis.Colonization resistance: The deconvolution of a complex trait.Loss of Multicellular Behavior in Epidemic African Nontyphoidal Salmonella enterica Serovar Typhimurium ST313 Strain D23580.Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1.NOD1 and NOD2 signalling links ER stress with inflammation.Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration.Loss of very-long O-antigen chains optimizes capsule-mediated immune evasion by Salmonella enterica serovar Typhi.PPARγ-mediated increase in glucose availability sustains chronic Brucella abortus infection in alternatively activated macrophages.Natural antibody contributes to host defense against an attenuated Brucella abortus virB mutant.Pathogenesis of bovine brucellosis.Neutrophils are a source of gamma interferon during acute Salmonella enterica serovar Typhimurium colitis.How to become a top model: impact of animal experimentation on human Salmonella disease research.Brucella spp. Virulence Factors and Immunity.Chronic Bacterial Pathogens: Mechanisms of Persistence.NOD1 and NOD2: New Functions Linking Endoplasmic Reticulum Stress and Inflammation.How bacterial pathogens use type III and type IV secretion systems to facilitate their transmission.Early MyD88-dependent induction of interleukin-17A expression during Salmonella colitis.Virulence factors enhance Citrobacter rodentium expansion through aerobic respiration.The Periplasmic Nitrate Reductase NapABC Supports Luminal Growth of Salmonella enterica Serovar Typhimurium during Colitis.Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion.Effect of extender supplementation with various antimicrobial agents on viability of Brucella ovis and Actinobacillus seminis in cryopreserved ovine semen.Genital lesions and distribution of amastigotes in bitches naturally infected with Leishmania chagasi.Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction.Venereal transmission of canine visceral leishmaniasis.Precision editing of the gut microbiota ameliorates colitis.Genetic Ablation of Butyrate Utilization Attenuates Gastrointestinal Salmonella Disease.Enteric pathology and Salmonella-induced cell death in healthy and SIV-infected rhesus macaques.The germ-organ theory of non-communicable diseases.
P50
Q27335357-DF02D17A-C2C3-400F-ADEF-E12A02D22524Q28483901-A6EDC2BC-FFBA-400A-8CE7-C04BEF8D47FEQ33553714-476A6967-2D50-461C-8C4A-1D954DAAB8D0Q33631244-BDB0BFCA-FEA1-4578-A477-0CC823BE8111Q34218409-3B53219B-1CC2-4F37-81BA-DFFB6F6AF4C0Q34253070-52B4FC1F-97F9-4140-9CEA-9FB37A10BFB9Q34634659-2A6F7874-F0BA-476A-9E5C-9B65B4B7E240Q34789335-E61FAE02-06D2-48B0-A62D-312B21464E38Q35409022-5B3B887A-17CC-4B0D-9296-79A913AD23B8Q35614774-4B93C436-23D2-44EE-84F2-DB5D8B9D0DF0Q35798458-0337E768-F1C5-4891-A29B-11BF8A262AC0Q35989778-EC60A5BB-F6D0-421C-928F-A7A7E2658687Q36240466-DEC08A62-0F3B-4FDA-9858-66E29B3E0B01Q36340549-63322DCD-91DD-46A8-9715-A5090F64A336Q36736283-554A2F30-A874-419A-BCDC-C8523D3BB414Q36763166-8EB564EE-66BA-44DE-A03C-59AE21EE0F06Q36908738-37F5C428-F2A3-4A5E-A973-FE6A18A7A414Q36994397-9EC3BF90-06CA-4462-A80C-E29838363A70Q37074488-A9D0F76F-A616-44CE-AFD3-69AD4BE7AB9FQ37184395-3740CE8D-A125-418B-832E-A3F2EED0B274Q37256467-50A2AD63-2DBF-450F-A1C2-3E9017D819BCQ37592524-10FFD80C-799D-4F48-B074-876B7612048BQ37713277-709C376F-0C2C-4AE5-BF7C-F1041484377CQ37845999-3CFEF1A0-5C6E-4A2B-9E97-D4CC125E64C9Q38687946-9AA2E9CD-6963-41FE-9940-C75C1AA476C4Q38844750-EA866054-705A-4595-AB66-7F926DB3450DQ38875982-451ADF1B-275F-477C-A76B-32A3CD81BF54Q38952810-4A0F7E8D-68C7-49F0-87ED-AA1867B12BB9Q39541537-1CEBE22B-BE84-42D6-A763-5EB62C43F314Q40538280-3D7A8CD4-C693-4900-9FEA-65255693089BQ41845880-3B2BB308-9652-45E8-8A18-0ADA9C4B918FQ42250704-572FF24A-7403-48E5-BE37-7FE9BC90EA05Q42937929-325FA381-C30A-40F8-BD56-AF6CE83A9518Q44589492-0BA8DCC0-E46A-425B-8407-23F9C1FF8C9AQ45957537-CC99C5DF-E8CB-4DF5-B9DD-519966EB0616Q46977786-8600EAD4-1E6D-4183-AEE7-35C3653593E5Q47660112-2BD8722F-CB15-4CEE-907E-57A24A1712EFQ49923752-F53816E7-1FF3-460F-BE11-0A5DCFB79771Q50045301-27525BEB-35FA-407D-84BF-7BF900C294E2Q50144039-1E8AB91A-CCB8-4A3E-BAA8-F7958E819314
P50
description
hulumtuese
@sq
onderzoeker
@nl
pathologist
@en
հետազոտող
@hy
name
Mariana N. Xavier
@ast
Mariana N. Xavier
@es
Mariana N. Xavier
@sl
Mariana Xavier Byndloss
@en
type
label
Mariana N. Xavier
@ast
Mariana N. Xavier
@es
Mariana N. Xavier
@sl
Mariana Xavier Byndloss
@en
altLabel
Mariana N. Xavier
@en
prefLabel
Mariana N. Xavier
@ast
Mariana N. Xavier
@es
Mariana N. Xavier
@sl
Mariana Xavier Byndloss
@en
P1053
D-9890-2014
P106
P1153
23111425900
P21
P2798
P31
P3829
P496
0000-0002-2122-4156